Newer type 2 diabetes drugs show heart protective quality in study
Sunday, March 19, 2017 - 14:11
in Health & Medicine
WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a so-called real world study sponsored by AstraZeneca.